ArticleThoracic cancer2019

ABCB1 polymorphism predicts the toxicity and clinical outcome of lung cancer patients with taxane-based chemotherapy.

Jia Zhong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.